GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ITRM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Iterum Therapeutics Plc stock upgraded from Strong Sell Candidate to Sell Candidate after Thursday trading session.
(Updated on Apr 18, 2024)

Sell candidate since Apr 16, 2024 Loss -1.38% PDF

The Iterum Therapeutics Plc stock price fell by -2.05% on the last day (Thursday, 18th Apr 2024) from $1.46 to $1.43. During the last trading day the stock fluctuated 2.10% from a day low at $1.43 to a day high of $1.46. The price has fallen in 8 of the last 10 days and is down by -23.53% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -19 thousand shares and in total, 57 thousand shares were bought and sold for approximately $81.11 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.24% during the next 3 months and, with a 90% probability hold a price between $1.14 and $1.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ITRM Signals & Forecast

There are few to no technical positive signals at the moment. The Iterum Therapeutics Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.54 and $1.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, April 04, 2024, and so far it has fallen -23.53%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Iterum Therapeutics Plc stock

Iterum Therapeutics Plc finds support from accumulated volume at $1.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0300 between high and low, or 2.10%. For the last week the stock has had daily average volatility of 5.45%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ITRM) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Iterum Therapeutics Plc to open at $1.44, and during the day (based on 14 day Average True Range), to move between $1.31 and $1.55, which gives a possible trading interval of +/-$0.117 (+/-8.17%) up or down from last closing price. If Iterum Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 16.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.42 (0.70%) than the resistance at $1.54 (7.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Iterum Therapeutics Plc stock A Buy?

Iterum Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.664 Sell Candidate Upgraded

Predicted Opening Price for Iterum Therapeutics Plc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.44 ( 0.699%) $1.43

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ITRM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 2.80 %
R2 1.46 2.00 %
R1 1.45 1.50 %
Current price: 1.43
Support S1 1.43 -0.102 %
S2 1.42 -0.597 %
S3 1.41 -1.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.65 15.38 %
R2 1.58 10.49 %
R1 1.54 7.69 %
Current price 1.43
Support S1 1.42 -0.699%
S2 1.27 -11.19%
S3 1.24 -13.29%

FAQ

What is the symbol for Iterum Therapeutics Plc Stock and on which exchange is it traded?
The symbol for Iterum Therapeutics Plc is ITRM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iterum Therapeutics Plc Stock?
Iterum Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Iterum Therapeutics Plc Stock?
Iterum Therapeutics Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iterum Therapeutics Plc Stock.

What's the current price of Iterum Therapeutics Plc Stock?
As of the end of day on the 2024-04-18, the price of an Iterum Therapeutics Plc (ITRM) share was $1.43.

What is the 52-week high and low for Iterum Therapeutics Plc Stock?
The 52-week high for Iterum Therapeutics Plc Stock is $2.50 and the 52-week low is $0.622.

What is the market capitalization of Iterum Therapeutics Plc Stock?
As of the 2024-04-18, the market capitalization of Iterum Therapeutics Plc is 23.983M.

When is the next earnings date for Iterum Therapeutics Plc?
The upcoming earnings date for Iterum Therapeutics Plc is May 10, 2024.
Click to get the best stock tips daily for free!

About Iterum Therapeutics Plc

Iterum Therapeutics Plc Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company ... ITRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT